Description

BSE announces listing of additional shares issued under ESOP/ESOS schemes by five companies including Bliss GVS Pharma, Federal Bank, IDFC FIRST Bank, InterGlobe Aviation, and SmartWorks Coworking Spaces, effective October 8, 2025.

Summary

BSE has announced the listing and admission for trading of further securities issued under ESOP/ESOS schemes by five companies. The new shares will be available for trading from Wednesday, October 8, 2025. This includes shares from Bliss GVS Pharma Limited, Federal Bank Ltd., IDFC FIRST BANK LIMITED, InterGlobe Aviation Limited, and SMARTWORKS COWORKING SPACES LIMITED.

Key Points

  • Five companies are listing additional shares issued through employee stock option schemes
  • Total of 810,996 new shares across all five companies
  • Effective trading date: October 8, 2025
  • Lock-in period applies only to Bliss GVS Pharma shares until March 15, 2026
  • Most shares have no lock-in restrictions

Company-Specific Details

Bliss GVS Pharma Limited

  • ISIN: INE416D01022
  • Scrip Code: 506197
  • Number of Shares: 39,950
  • Face Value: ₹1
  • Lock-in Period: Until March 15, 2026

Federal Bank Ltd.

  • ISIN: INE171A01029
  • Scrip Code: 500469
  • Number of Shares: 44,995
  • Face Value: ₹2
  • Lock-in Period: None

IDFC FIRST BANK LIMITED

  • ISIN: INE092T01019
  • Scrip Code: 539437
  • Number of Shares: 576,888
  • Face Value: ₹10
  • Lock-in Period: None

InterGlobe Aviation Limited

  • ISIN: INE646L01027
  • Scrip Code: 539448
  • Number of Shares: 25,063
  • Face Value: ₹10
  • Lock-in Period: None

SMARTWORKS COWORKING SPACES LIMITED

  • ISIN: INE0NAZ01010
  • Scrip Code: 544447
  • Number of Shares: 123,100
  • Face Value: ₹10
  • Lock-in Period: None

Regulatory Changes

No regulatory changes announced in this circular.

Compliance Requirements

Trading members are informed to note the new securities for trading purposes. No specific compliance actions required from trading members beyond awareness of the new listings.

Important Dates

  • Notice Date: October 7, 2025
  • Trading Commencement Date: October 8, 2025
  • Lock-in Expiry (Bliss GVS Pharma only): March 15, 2026

Impact Assessment

This is a routine administrative listing with minimal market impact. The additional shares represent ESOP/ESOS exercises and constitute a small percentage of the total outstanding shares for each company. Only Bliss GVS Pharma shares are subject to lock-in restrictions. The listing provides liquidity to employees who have exercised their stock options and allows these shares to be traded on the exchange.

Impact Justification

Routine listing of ESOP/ESOS shares with minimal market impact; affects only specific employee stock option exercises